RxDoctor Payments DataLook up a doctor →

Michael Zaragoza, MD

Urology · Dover, DENPI 1205821881

Payments from drug & device makers

$6,189in general payments, 2019–2025

Across 310 payments — averaging $19.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$1K
  • Sumitomo Pharma America, Inc.$660
  • Johnson & Johnson$604
  • AbbVie$447
  • Bayer$280
  • Pfizer$232
  • plus $3K from 41 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc49$1,010
Sumitomo Pharma America, Inc.39$660
Johnson & Johnson(3 entities)36$604
AbbVie(2 entities)22$447
Bayer15$280
Pfizer16$232
Ferring Pharmaceuticals Inc.11$187
Teleflex LLC7$168
Progenics Pharmaceuticals, Inc.7$168
Laborie Medical Technologies Corp.3$161
Amgen7$147
Procept Biorobotics Corporation6$134
Verity Pharmaceuticals Inc.8$129
Boston Scientific5$129
Merck6$129
Neotract Inc.2$125
Accord Healthcare, Inc.6$118
Immunitybio, Inc.5$104
Urovant Sciences Inc4$83
AstraZeneca3$79
Coloplast3$78
Dendreon Pharmaceuticals LLC3$74
Bluewind Medical2$62
C. R. Bard, Inc. & Subsidiaries3$60
Novartis3$57
Rochester Medical Corporation2$55
Blue Earth Diagnostics3$54
Bioprotect Medical, Inc.3$53
Endo Pharmaceuticals Inc.4$52
Biocomposites Inc1$49
Urogen Pharma, Inc.2$47
Tolmar, Inc.2$45
Olympus America Inc.2$41
Baxter Healthcare2$41
Avadel Specialty Pharmaceuticals, LLC2$38
Medtronic2$37
Agiliti Surgical, Inc.1$34
Myovant Sciences Inc.2$30
Acerus Pharmaceuticals Corporation2$29
Axonics, Inc.1$27
Myriad Genetic Laboratories, Inc.2$26
Photocure Inc1$25
Foundation Medicine, Inc.1$20
180 Medical, Inc.1$18
Abbott1$18
Calyxo, Inc.1$14
Travere Therapeutics, Inc.1$13

How this compares

$6,189 in reported general payments places this provider in the 80th percentile of 33 urology providers in Delaware.

See all urology providers in Delaware →

Medicare billing

Part B allowed, 2024
$763,670
Medicare patients
1,131
Services billed
23,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Dover

See the full list for Delaware →

Where these figures come from

Is this you, or does something look wrong? →